Aptos vs Injective Staking
Side-by-side comparison of APT and INJ staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Aptos vs Injective: which should you stake?
Aptos currently offers the higher APY at 13.09% compared to Injective's 8.00%. That's a 5.09 percentage point difference in annual yield.
In terms of market cap, Aptos is the larger asset at $653.92M, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Aptos vs Injective — common questions
Is Aptos or Injective better for staking?
Aptos currently offers a higher staking APY at 13.09% compared to Injective's 8.00%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Aptos and Injective?
Aptos offers 13.09% APY while Injective offers 8.00% APY — a difference of 5.09 percentage points.
Which is safer to stake: APT or INJ?
Aptos has a medium risk rating while Injective has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both APT and INJ?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Aptos and Injective spreads your risk across different networks and protocols.